Showing 1 posts of 1 posts found.
Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO